BRIEF-Diurnal Group says primary endpoint met in Infacort late-stage study

* Positive headline data from pivotal study for Infacort in Europe for paediatric adrenal insufficiency (AI)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.